Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$236M |
| 2 |
AbbVie
ABBV
|
+$159M |
| 3 |
Sysco
SYY
|
+$136M |
| 4 |
FedEx
FDX
|
+$135M |
| 5 |
Coca-Cola
KO
|
+$126M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$306M |
| 2 |
Apple
AAPL
|
+$215M |
| 3 |
Union Pacific
UNP
|
+$193M |
| 4 |
Alibaba
BABA
|
+$177M |
| 5 |
Walmart
WMT
|
+$174M |
Sector Composition
| 1 | Healthcare | 13.17% |
| 2 | Financials | 11.79% |
| 3 | Technology | 11.03% |
| 4 | Consumer Staples | 10.42% |
| 5 | Industrials | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Supernus Pharmaceuticals
SUPN
$2.51B
| $1.76M | ﹤0.01% |
125,100
+10,100
| +9% | +$142K |
|
2077
Bristow Group
VTOL
$1.08B
| $1.75M | ﹤0.01% |
+58,600
| New | +$1.75M |
|
2078
QuidelOrtho
QDEL
$1.95B
| $1.75M | ﹤0.01% |
92,700
+24,113
| +35% | +$455K |
|
2079
Crocs
CROX
$4.4B
| $1.75M | ﹤0.01% |
+135,094
| New | +$1.75M |
|
2080
Luxfer Holdings
LXFR
$375M
| $1.75M | ﹤0.01% |
161,800
-711
| -0.4% | -$7.67K |
|
|
MSON
2081
DELISTED
Misonix Inc
MSON
| $1.75M | ﹤0.01% |
162,697
+23,000
| +16% | +$247K |
|
|
GWB
2082
DELISTED
Great Western Bancorp, Inc.
GWB
| $1.75M | ﹤0.01% |
68,800
-177,253
| -72% | -$4.5M |
|
|
ALDW
2083
DELISTED
Alon USA Partners, LP
ALDW
| $1.74M | ﹤0.01% |
+74,800
| New | +$1.74M |
|
2084
Crown Crafts
CRWS
$30.5M
| $1.74M | ﹤0.01% |
212,300
+17,700
| +9% | +$145K |
|
|
COVS
2085
DELISTED
Covisint Corporation
COVS
| $1.74M | ﹤0.01% |
809,000
-206,408
| -20% | -$444K |
|
2086
Timberland Bancorp
TSBK
$280M
| $1.74M | ﹤0.01% |
159,600
+4,700
| +3% | +$51.2K |
|
2087
Utilities Select Sector SPDR Fund
XLU
$20.9B
| $1.74M | ﹤0.01% |
40,100
+32,800
| +449% | +$1.42M |
|
2088
Global Net Lease
GNL
$1.79B
| $1.73M | ﹤0.01% |
+62,833
| New | +$1.73M |
|
|
RC
2089
Ready Capital
RC
$698M
| $1.73M | ﹤0.01% |
129,416
+4,567
| +4% | +$61.2K |
|
2090
Select Medical
SEM
$1.52B
| $1.73M | ﹤0.01% |
+297,558
| New | +$1.73M |
|
2091
Green Brick Partners
GRBK
$3.13B
| $1.73M | ﹤0.01% |
159,635
-142,742
| -47% | -$1.55M |
|
|
INTX
2092
DELISTED
Intersections, Inc.
INTX
| $1.72M | ﹤0.01% |
828,800
+25,800
| +3% | +$53.7K |
|
|
HIL
2093
DELISTED
Hill International, Inc. Common Stock
HIL
| $1.72M | ﹤0.01% |
524,800
+87,304
| +20% | +$286K |
|
|
LSG
2094
DELISTED
LAKE SHORE GOLD CORP
LSG
| $1.72M | ﹤0.01% |
2,068,398
-1,150,000
| -36% | -$957K |
|
2095
Daktronics
DAKT
$1.1B
| $1.72M | ﹤0.01% |
197,900
-5,700
| -3% | -$49.4K |
|
2096
Coherus Oncology, Inc. Common Stock
CHRS
$157M
| $1.71M | ﹤0.01% |
85,500
+44,593
| +109% | +$893K |
|
|
WRI
2097
DELISTED
Weingarten Realty Investors
WRI
| $1.71M | ﹤0.01% |
51,600
+5,200
| +11% | +$172K |
|
2098
Anika Therapeutics
ANIK
$125M
| $1.71M | ﹤0.01% |
53,600
-63,600
| -54% | -$2.02M |
|
|
GEN
2099
DELISTED
Genesis Healthcare, Inc.
GEN
| $1.7M | ﹤0.01% |
277,600
+23,700
| +9% | +$145K |
|
2100
Corcept Therapeutics
CORT
$7.92B
| $1.7M | ﹤0.01% |
452,200
-49,414
| -10% | -$186K |
|